Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001415889-24-028976
Filing Date
2024-12-11
Accepted
2024-12-11 16:45:15
Documents
1
Period of Report
2024-12-09

Document Format Files

Seq Description Document Type Size
1 form4-12112024_041211.html 4  
1 form4-12112024_041211.xml 4 4200
  Complete submission text file 0001415889-24-028976.txt   5727
Mailing Address 4225 EXECUTIVE SQUARE SUITE 600 LA JOLLA CA 92037
Business Address 4225 EXECUTIVE SQUARE SUITE 600 LA JOLLA CA 92037 858-247-0520
Zura Bio Ltd (Issuer) CIK: 0001855644 (see all company filings)

EIN.: 000000000 | State of Incorp.: E9 | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)

Mailing Address 2748 BUSH STREET SAN FRANCISCO CA 94115
Business Address
Schoch Steven J (Reporting) CIK: 0001867508 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-40598 | Film No.: 241542073